JP2014520886A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520886A5 JP2014520886A5 JP2014521705A JP2014521705A JP2014520886A5 JP 2014520886 A5 JP2014520886 A5 JP 2014520886A5 JP 2014521705 A JP2014521705 A JP 2014521705A JP 2014521705 A JP2014521705 A JP 2014521705A JP 2014520886 A5 JP2014520886 A5 JP 2014520886A5
- Authority
- JP
- Japan
- Prior art keywords
- het
- atoms
- physiologically acceptable
- compound according
- hal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 102000008175 FSH Receptors Human genes 0.000 claims 3
- 108010060374 FSH Receptors Proteins 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 102000002322 Egg Proteins Human genes 0.000 claims 2
- 108010000912 Egg Proteins Proteins 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 208000021267 infertility disease Diseases 0.000 claims 2
- 210000004681 ovum Anatomy 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000004720 fertilization Effects 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 0 CCCS(CCCc(cc1)c(*C(c2ccc[o]2)=O)cc1C(CCC*(C(CC1)=O)C1=O)=O)c1ccccc1C Chemical compound CCCS(CCCc(cc1)c(*C(c2ccc[o]2)=O)cc1C(CCC*(C(CC1)=O)C1=O)=O)c1ccccc1C 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161508861P | 2011-07-18 | 2011-07-18 | |
| US61/508,861 | 2011-07-18 | ||
| US201161526342P | 2011-08-23 | 2011-08-23 | |
| US61/526,342 | 2011-08-23 | ||
| PCT/US2012/047038 WO2013012848A1 (en) | 2011-07-18 | 2012-07-17 | Benzamides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017043934A Division JP6254730B2 (ja) | 2011-07-18 | 2017-03-08 | ベンズアミド類 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520886A JP2014520886A (ja) | 2014-08-25 |
| JP2014520886A5 true JP2014520886A5 (https=) | 2017-06-15 |
| JP6162694B2 JP6162694B2 (ja) | 2017-07-12 |
Family
ID=46551951
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014521705A Expired - Fee Related JP6162694B2 (ja) | 2011-07-18 | 2012-07-17 | ベンズアミド類 |
| JP2017043934A Expired - Fee Related JP6254730B2 (ja) | 2011-07-18 | 2017-03-08 | ベンズアミド類 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017043934A Expired - Fee Related JP6254730B2 (ja) | 2011-07-18 | 2017-03-08 | ベンズアミド類 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9181226B2 (https=) |
| EP (2) | EP2734517B1 (https=) |
| JP (2) | JP6162694B2 (https=) |
| CN (1) | CN103702993B (https=) |
| AU (2) | AU2012284184B2 (https=) |
| CA (1) | CA2834199C (https=) |
| ES (2) | ES2649995T3 (https=) |
| IL (1) | IL230463A (https=) |
| WO (1) | WO2013012848A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2734517B1 (en) * | 2011-07-18 | 2017-08-30 | Merck Patent GmbH | Benzamides |
| WO2013106409A1 (en) | 2012-01-10 | 2013-07-18 | Merck Patent Gmbh | Benzamide derivatives as modulators of the follicle stimulating hormone |
| EP2941423B1 (en) | 2013-01-07 | 2021-06-09 | University of Southern California | Deoxyuridine triphosphatase inhibitors |
| SG11201505999VA (en) | 2013-03-11 | 2015-08-28 | Merck Patent Gmbh | 6-[4-(1 h-imidazol-2-yl)piperidin-1 -yl]pyrimidin-4-amine derivatives as modulators of kinase activity |
| CN104717415B (zh) * | 2013-12-12 | 2019-03-01 | 华为技术有限公司 | 一种摄像装置 |
| WO2015196335A1 (en) | 2014-06-23 | 2015-12-30 | Tocopherx, Inc. | Pyrazole compounds as modulators of fshr and uses thereof |
| EP3227277B1 (en) * | 2014-12-05 | 2020-02-05 | Pulmocide Limited | Antimycotic compound |
| US10577321B2 (en) | 2015-07-08 | 2020-03-03 | University Of Southern California | Deoxyuridine triphosphatase inhibitors |
| WO2017006271A1 (en) | 2015-07-08 | 2017-01-12 | University Of Southern California | Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage |
| WO2017006283A1 (en) | 2015-07-08 | 2017-01-12 | Cv6 Therapeutics (Ni) Limited | Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage |
| SI3319939T1 (sl) | 2015-07-08 | 2025-04-30 | Cv6 Therapeutics (Ni) Limited | Zaviralci deoksiuridin trifosfataze, ki vsebujejo hidantoin |
| EP3365324A1 (en) | 2015-10-22 | 2018-08-29 | The Procter and Gamble Company | Synthesis of cyclohexane carboxamide derivatives useful as sensates in consumer products |
| WO2018098208A1 (en) | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | Nitrogen ring linked deoxyuridine triphosphatase inhibitors |
| US11168059B2 (en) | 2016-11-23 | 2021-11-09 | Cv6 Therapeutics (Ni) Limited | Amino sulfonyl compounds |
| WO2018098204A1 (en) | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | 6-membered uracil isosteres |
| WO2018128720A1 (en) | 2017-01-05 | 2018-07-12 | Cv6 Therapeutics (Ni) Limited | Uracil containing compounds |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07258224A (ja) * | 1994-03-24 | 1995-10-09 | Dai Ichi Seiyaku Co Ltd | 二環性化合物 |
| JPH0959236A (ja) * | 1995-08-23 | 1997-03-04 | Dai Ichi Seiyaku Co Ltd | ベンズアミド化合物 |
| EP0887340A4 (en) | 1996-02-06 | 2000-03-29 | Japan Tobacco Inc | CHEMICAL COMPOUNDS AND THEIR PHARMACEUTICAL USE |
| FR2765221B1 (fr) * | 1997-06-25 | 1999-07-30 | Synthelabo | Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique |
| AR013693A1 (es) * | 1997-10-23 | 2001-01-10 | Uriach & Cia Sa J | Nuevas piperidinas y piperazinas como inhibidores de la agregacion plaquetaria |
| CA2339018A1 (en) | 1998-08-07 | 2000-02-17 | Applied Research Systems Ars Holding N.V. | Fsh mimetics for the treatment of infertility |
| US7101878B1 (en) * | 1998-08-20 | 2006-09-05 | Agouron Pharmaceuticals, Inc. | Non-peptide GNRH agents, methods and intermediates for their preparation |
| RU2260007C2 (ru) | 1999-03-17 | 2005-09-10 | Астразенека Аб | Производные амида, способ их получения (варианты), фармацевтическая композиция, способ ингибирования |
| SE9904652D0 (sv) * | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
| EP1307193A1 (en) | 2000-07-27 | 2003-05-07 | Affymax Research Institute | Agonists of follicle stimulating hormone activity |
| US20040010033A1 (en) * | 2001-02-20 | 2004-01-15 | Pfizer Inc. | Non-peptide GnRH agents, methods and intermediates for their preparation |
| SE0101387D0 (sv) | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
| WO2003068769A1 (en) * | 2002-02-12 | 2003-08-21 | Pfizer Inc. | Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh) |
| BR0312123A (pt) * | 2002-06-13 | 2005-03-29 | Pfizer | Agentes de gnrh não peptìdicos, composições farmacêuticas e métodos para o seu uso |
| ES2399047T3 (es) * | 2002-09-20 | 2013-03-25 | Merck Serono Sa | Derivados de piperazina y procedimiento de uso |
| SE0203070D0 (en) | 2002-10-16 | 2002-10-16 | Astrazeneca Ab | Novel compounds |
| FR2851563B1 (fr) * | 2003-02-26 | 2005-04-22 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament |
| US7700583B2 (en) * | 2003-04-11 | 2010-04-20 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
| FR2862971B1 (fr) * | 2003-11-28 | 2006-03-24 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament |
| JPWO2005108370A1 (ja) * | 2004-04-16 | 2008-03-21 | 味の素株式会社 | ベンゼン化合物 |
| WO2006080477A1 (en) * | 2005-01-25 | 2006-08-03 | Tanabe Seiyaku Co., Ltd. | Norvaline derivative and method for preparation thereof |
| EP1899353A1 (en) * | 2005-06-22 | 2008-03-19 | DeveloGen Aktiengesellschaft | Thienopyrimidines for pharmaceutical compositions |
| WO2007002742A1 (en) * | 2005-06-28 | 2007-01-04 | Pharmacopeia, Inc. | Substituted [1,4]-diazepanes as cxcr3 antagonists and their use in the treatment of inflammatory disorders |
| WO2007008541A2 (en) * | 2005-07-08 | 2007-01-18 | Kalypsys, Inc. | Cellular cholesterol absorption modifiers |
| AU2006296004B2 (en) * | 2005-09-27 | 2011-11-17 | Shionogi & Co., Ltd. | Sulfonamide derivative having PGD2 receptor antagonistic activity |
| CA2651898A1 (en) * | 2006-04-07 | 2007-10-18 | Develogen Aktiengesellschaft | Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| US20110071130A1 (en) * | 2006-05-08 | 2011-03-24 | Pharmacopeia, Inc. | 2-aminobenzimidazoles for treating neurodegenerative diseases |
| MX2009009304A (es) | 2007-03-01 | 2009-11-18 | Novartis Ag | Inhibidores de cinasa pim y metodos para su uso. |
| US20140249135A1 (en) * | 2007-03-01 | 2014-09-04 | Novartis Ag | Pim kinase inhibitors and methods of their use |
| GB0705656D0 (en) | 2007-03-23 | 2007-05-02 | Addex Pharmaceuticals Sa | Novel compounds E1 |
| WO2008123469A1 (ja) * | 2007-03-30 | 2008-10-16 | Japan Tobacco Inc. | ６員環アミド化合物およびその用途 |
| CL2008000986A1 (es) * | 2007-04-06 | 2008-10-17 | Neurocrine Biosciences Inc | COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV |
| EP2219649A2 (en) * | 2007-11-22 | 2010-08-25 | Boehringer Ingelheim International Gmbh | Use of mnk inhibitors for the treatment of alzheimer's disease |
| CA2709784A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| PE20091576A1 (es) * | 2008-02-19 | 2009-11-05 | Sanofi Aventis | DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3 |
| UY32138A (es) * | 2008-09-25 | 2010-04-30 | Boehringer Ingelheim Int | Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables |
| US20100137386A1 (en) * | 2008-12-01 | 2010-06-03 | Tesshi Yamada | Tnik inhibitor and the use |
| US8969342B2 (en) * | 2009-03-20 | 2015-03-03 | Brandeis University | Compounds and methods for treating mammalian gastrointestinal microbial infections |
| TWI461426B (zh) | 2009-05-27 | 2014-11-21 | Merck Sharp & Dohme | （二氫）咪唑並異〔５，１－ａ〕喹啉類 |
| CA2837524C (en) * | 2011-07-01 | 2019-08-20 | Merck Patent Gmbh | Dihydropyrazoles |
| EP2734517B1 (en) * | 2011-07-18 | 2017-08-30 | Merck Patent GmbH | Benzamides |
| WO2013106409A1 (en) * | 2012-01-10 | 2013-07-18 | Merck Patent Gmbh | Benzamide derivatives as modulators of the follicle stimulating hormone |
-
2012
- 2012-07-17 EP EP12738368.5A patent/EP2734517B1/en active Active
- 2012-07-17 CN CN201280035159.6A patent/CN103702993B/zh not_active Expired - Fee Related
- 2012-07-17 ES ES12738368.5T patent/ES2649995T3/es active Active
- 2012-07-17 AU AU2012284184A patent/AU2012284184B2/en not_active Ceased
- 2012-07-17 US US13/551,072 patent/US9181226B2/en active Active
- 2012-07-17 JP JP2014521705A patent/JP6162694B2/ja not_active Expired - Fee Related
- 2012-07-17 CA CA2834199A patent/CA2834199C/en active Active
- 2012-07-17 ES ES17187673T patent/ES2899000T3/es active Active
- 2012-07-17 WO PCT/US2012/047038 patent/WO2013012848A1/en not_active Ceased
- 2012-07-17 EP EP17187673.3A patent/EP3263568B1/en active Active
-
2014
- 2014-01-15 IL IL230463A patent/IL230463A/en active IP Right Grant
-
2015
- 2015-09-24 US US14/863,865 patent/US9498475B2/en not_active Expired - Fee Related
-
2016
- 2016-10-03 US US15/283,938 patent/US9938262B2/en active Active
-
2017
- 2017-02-14 AU AU2017200985A patent/AU2017200985A1/en not_active Abandoned
- 2017-03-08 JP JP2017043934A patent/JP6254730B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014520886A5 (https=) | ||
| JP6257326B2 (ja) | 神経因性疼痛におけるマロノニトリルアミドの使用 | |
| JP2021527092A5 (https=) | ||
| JP2015529229A5 (https=) | ||
| RS53716B1 (sr) | Kombinovana terapija kancera sa hsp90 inhibitornim jedinjenjima | |
| CN109311832A (zh) | 沃替西汀的帕莫酸盐及其晶型 | |
| JP2016507500A5 (https=) | ||
| ES2333805T3 (es) | Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos. | |
| WO2024041330A1 (zh) | Ly2922470在制备预防或治疗脑血管疾病或组织缺血再灌注损伤药物中的应用 | |
| RU2015134420A (ru) | Кристаллические формы { [1-циано-5-(4-хлорофеноксид)-4-гидроксид-изохинолин-3-карбонил]-амино} -уксусной кислоты | |
| RU2013127420A (ru) | Способы уменьшения психогенного или компульсивного переедания | |
| KR20200068659A (ko) | 3-치환된 1,2,4-옥사다이아졸의 결정질 형태 | |
| Liu et al. | Protective effects of estrogen combined with sevoflurane in an experimental model of cerebral infarction and focal cerebral ischemia-reperfusion injury. | |
| JP2013500982A (ja) | ＰＰＡＲγのベンズイミダゾール誘導体作動薬で神経因性疼痛を治療する方法 | |
| WO2018200357A1 (en) | Methods and compositions of improving fertility | |
| JP6642892B2 (ja) | ジメチルアミノミケリオリドを含む肺線維化の治療薬 | |
| JP6960415B2 (ja) | 三叉神経痛を予防又は治療する目的のためのカルバメート化合物の使用 | |
| ES3054693T3 (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| EA201101622A1 (ru) | Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования | |
| CA2876926C (en) | Composition for treating or preventing vascular permeability-related disease containing imatinib or pharmaceutically acceptable salt thereof as active ingredient | |
| CN105078944A (zh) | Isopaucifloral F在制备抗骨质疏松药物中的用途 | |
| JP2015524460A5 (https=) | ||
| JP2012513443A5 (https=) | ||
| KR102687556B1 (ko) | 종양 전이를 억제하는 방법 | |
| CN107427508B (zh) | 异喹啉衍生物用于糖尿病伤口愈合的用途 |